Artivion (AORT) Cash & Equivalents Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28% |
| Dec 31, 2025 | 1.11% |
| Sep 30, 2025 | 2.75% |
| Jun 30, 2025 | -15.70% |
| Mar 31, 2025 | -9.87% |
| Dec 31, 2024 | 9.63% |
| Sep 30, 2024 | 8.89% |
| Jun 30, 2024 | 6.72% |
| Mar 31, 2024 | 4.85% |
| Dec 31, 2023 | 7.27% |
| Sep 30, 2023 | 9.13% |
| Jun 30, 2023 | 14.34% |
| Mar 31, 2023 | 2.97% |
| Dec 31, 2022 | -0.32% |
| Sep 30, 2022 | -28.62% |
| Jun 30, 2022 | -5.12% |
| Mar 31, 2022 | -2.68% |
| Dec 31, 2021 | -0.58% |
| Sep 30, 2021 | 3.60% |
| Jun 30, 2021 | 1.46% |
| Mar 31, 2021 | 4.76% |
| Dec 31, 2020 | 10.32% |
| Sep 30, 2020 | 10.74% |
| Jun 30, 2020 | 29.07% |
| Mar 31, 2020 | 14.35% |
| Dec 31, 2019 | 0.23% |
| Sep 30, 2019 | 4.23% |
| Jun 30, 2019 | 5.18% |
| Mar 31, 2019 | 4.25% |
| Dec 31, 2018 | 1.96% |
| Sep 30, 2018 | 14.35% |
| Jun 30, 2018 | 16.30% |
| Mar 31, 2018 | 25.23% |
| Dec 31, 2017 | 25.17% |
| Sep 30, 2017 | 47.42% |
| Jun 30, 2017 | 67.36% |
| Mar 31, 2017 | 22.73% |
| Dec 31, 2016 | 21.15% |
| Sep 30, 2016 | 20.79% |
| Jun 30, 2016 | 18.84% |
| Mar 31, 2016 | 3.59% |
| Dec 31, 2015 | 1.15% |
| Sep 30, 2015 | 4.43% |
| Jun 30, 2015 | -0.60% |
| Dec 31, 2014 | 2.07% |